UK regulatory update: CE marking recognition in Great Britain

PhaRegistrum · Originally published on 13/11/2026

Good news for medical device manufacturers!

On 21 October 2026, the UK Government confirmed that CE-marked medical devices and in vitro diagnostic devices (IVDs), already approved for the EU market, will be recognised in Great Britain without the need for the additional UKCA approval route.

For manufacturers operating across the EU and UK, this decision represents an important step towards regulatory alignment and more efficient market access.

What does this mean?

  • CE-marked medical devices and IVDs can continue to access the Great Britain market under the applicable regulatory framework.
  • It avoids unnecessary duplication of conformity assessment procedures for devices already approved for the EU market.
  • It provides long-term certainty for manufacturers planning their UK market strategy.
  • The UKCA marking pathway will continue alongside CE recognition.

Attention: indefinite CE recognition does not eliminate other applicable UK regulatory obligations, including MHRA registration and post-market surveillance requirements.

View original post on LinkedIn

Back to the publication archive